PubMed laboratory research record [PMID: 864359] PubMed record related to this compound for laboratory literature review
As a modified fragment of human growth hormone, it provides a model system for studying how specific peptide domains influence receptor interaction and downstream signaling
Lyophilized Powder: 5mg/Vial, 10mg/Vial
Orforglipron In phase II, randomized, double-blind study, adults with overweight or obesity and without T2DM who took oral orforglipron (12, 24, 36, or 45 mg) daily for 36 weeks experienced a weight reduction of 9.414.7% [105]
More about hydroxocobalamin Check interactions Compare alternatives Pricing & coupons Reviews (2) Latest FDA alerts (1) Side effects Dosage information During pregnancy Drug class: vitamins En espaol Patient resources Hydroxocobalamin injection drug information Hydroxocobalamin (Advanced Reading) Hydroxocobalamin Injection (Cyanide Poisoning)